Fingolimod HCL CAS 162359-56-0

Pwodwi Deskripsyon:

Non pwodwi: Fingolimod HCL CAS NON: 162359-56-0

Sinonim:

Fingolimod hydrochloride; FTY-720A;

1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-, hydrochloride;

2-Amino-2-(4-octylphenethyl) pwopan-1,3-diolol hydrochoride;

2-Amino-2-[2-(4-n-octylphenyl)pwopan-1,3-diol Hydrochoride;

Chimik & Pwopriyete fizik:

Aparans : Blan a solid blan

Assay: ≥99.0%

Dansite: 1.016g / cm³

Fonn pwen: 102-107° C

Bouyi pwen: 479.5 ° C nan 760 mmHg

Flash Pwen: 243.8 ° C

Endeks refraktif: 1.531

Vapore Presyon: 5.28E-10mmHg nan 25 ° C

PSA: 66.48000

LogP: 4.70660

Solibilite: DMSO (yon ti kras), Metanol (yon ti kras), dlo (yon ti kras)

Kategori: Creole; Aktivate anzim ak Inhibitors; Pharmaceutiical / API Dwog Enpurte / Metabolites;

Enfomasyon sekirite:

HS Kod: 2922190900

Deklarasyon Danje: H315; H319; H335; H412

Siyal Pawol: Avetisman

Deklarasyon Prensipal: P261; P273; P305 + P351 + P338

senbol: GHS07

Depo:Estoke nan yon veso fre ak sek ki byen femen. Kenbe lwen imidite ak limye fo / chale.

Aplikasyon:

1.Fingolimod, chimikman li te ye tankou 2-Amino-2-(4-octylphenethyl) pwopan-1,3-diol hydrochloride, se yon ajan iminosuppressive klinik itilize pou tretman an nan renouvlab esklewoz miltip.

2. Fingolimod hydrochloride se yon sphingosine 1-fosfate (S1P) antagonist ak yon IC50 nan 0.033 NM nan K562 ak NK selil yo.

Faktori faktori nou an Fingolimod HCL CAS 162359-56-0, teknoloji matirite, pwodiksyon ki estab, asirans kalite.

Estati envante: nan stock.

Nou ka bay CAS 162359-56-0 COA (setifika analiz), 2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diolol hydrocholide MOA (Metod nan analiz), 2-Amino-2-(2-(4-octylphenyl) ethyl) pwopan-n-2-(4-octylphenyl)pwopan-n) 1, 3-diol Hydrochloride ROS (Wout nan sentez), 2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol chlorhydrate MSDS (Materyel Sekirite Done Fey) ak lot sipo pou ou!

Fingolimod hydrochloride se premye dwog la oral itilize yo trete sclerosis miltip. Li te avek sikse devlope pa Novartis Famasetik e li te apwouve pou maketing pa Administrasyon an US ak Administrasyon Dwog (FDA). Doz rekomande a se 0.5 mg oralman yon fwa pa jou. Sclerosis miltip se yon maladi nerolojik nerolojik ki ka lakoz pasyan yo pedi balans, kranp doule misk ak lot malfonksyonman mote. Maladi a te toujou trete ak dwog enjekte, ki pote gwo benefis pou pasyan yo. Enkonvenyans la.

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a manti selman ak achte a.

Baj popilè: fingolimod hcl cas 162359-56-0, manifaktire, founise, faktori, achte, nan stock

• On: 3-(2S,5S)-tetrahydro-5-((3R,5R) -3-hydroxy-6-iodo-5-methy 6-enyl) -4-methylenefuran-2-yl)propyl Pivalate CAS 157322-47-9
• Pwochen: Diethyl 2-acetamido-2- (4-octylphenethyl) malonat CAS 162358-08-9